Edition:
United Kingdom

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

6.20USD
23 Aug 2019
Change (% chg)

$-0.10 (-1.59%)
Prev Close
$6.30
Open
$6.29
Day's High
$6.29
Day's Low
$5.99
Volume
3,647
Avg. Vol
13,730
52-wk High
$7.95
52-wk Low
$2.10

About

Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for... (more)

Overall

Beta: --
Market Cap(Mil.): $56.33
Shares Outstanding(Mil.): 10.04
Dividend: --
Yield (%): --

Financials

  ATXI.OQ Industry Sector
P/E (TTM): -- 29.89 32.67
EPS (TTM): -0.53 -- --
ROI: -- 14.89 14.48
ROE: -- 16.01 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates